Method for treatment of reactive arthritis or bursitis
US6465473B1 · kind B1 · utility
7Cited by
1References
19Claims
0Family size
Inventors
Key dates
| Filing date | Feb 22, 2000 |
| Grant date | Oct 15, 2002 |
| Priority date | — |
| Expiry date | Feb 22, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/65
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An improved method for treatment of conditions in human beings associated with either or both reactive arthritis or bursitis comprising administration of a combination of L-lysine, minocycline hydrochloride, metronidazole, and valacyclovir hydrochloride. A first alternate method comprises administration of L-lysine, minocycline hydrochloride, and metronidazole. A second alternate method comprises administration of L-lysine, minocycline hydrochloride, metronidazole, and isonicotinic acid hydrazide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.